Ignite Creation Date:
2024-05-06 @ 7:35 PM
Last Modification Date:
2024-10-26 @ 3:10 PM
Study NCT ID:
NCT06068881
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-06-03
First Post:
2023-09-29
Brief Title:
A Study to Assess Efficacy and Safety of Oral Tazemetostat in Adult Participants With RelapsedRefractory Follicular Lymphoma That Does Not Have an EZH2 Gain-of-function Genetic Mutation
Sponsor:
Epizyme Inc
Organization:
Ipsen
Organization Data
Organization:
Ipsen
Class:
INDUSTRY
Study ID:
CLIN-60200-452
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Epizyme Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Ipsen | INDUSTRY |